Assignee
DECIBEL THERAPEUTICS INC
US·12 granted patents·24 pending applications·34 citations·filing 2019–2025
Top patents by PatentIndex Score
36 records- 0196US11071751B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2020·Granted Jul 27, 2021·5 cites·20 claims
- 0293US11857567B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·2 cites·22 claims
- 0393US10709732B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·6 cites·33 claims
- 0489US11690870B2Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2020·Granted Jul 4, 2023·2 cites·10 claims
- 0588US12252520B2Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2021·Granted Mar 18, 2025·2 cites·13 claims
- 0688US11660353B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2019·Granted May 30, 2023·9 cites·11 claims
- 0785US10813947B1Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·5 cites·7 claims
- 0883US2024350533A1Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0982US12233136B2Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2019·Granted Feb 25, 2025·3 cites·25 claims
- 1078US2025381219A1Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1175US2025127926A1Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1274US2024226141A9Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1372US2026035716A1Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1470US2024226326A9Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1567US2024352483A1Modified rep-cap plasmids and uses thereofDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1666US2024309399A1Methods and compositions for administering otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1765US12410442B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2021·Granted Sep 9, 2025·0 cites·19 claims
- 1861US12545930B2Cochlear inner hair cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Granted Feb 10, 2026·0 cites·12 claims
- 1960US2025304637A1Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2059US2025127928A1Gjb2 regulatory elements and uses thereofDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2158US12589168B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2022·Granted Mar 31, 2026·0 cites·4 claims
- 2258US2024401079A1Stereocilin promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2357US2025319205A1Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2457US2026034248A1Slc26a4 regulatory elements and uses thereofDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2555US2024285803A1Compositions and methods for cell type-specific gene expression in the inner earDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2654US2022288236A1Cochlear outer hair cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2754US2022054640A1Compositions and methods for the delivery of therapeutic agents across the round window membraneDECIBEL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2854US2024218391A1Vestibular supporting cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2954US2024002839A1Crispr sam biosensor cell lines and methods of use thereofDECIBEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3054US2022331449A1Vestibular supporting cell promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3152US2024216540A1Compositions and methods for treating sensorineural hearing loss using stereocilin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3252US2024226331A9Methods and compositions for reducing nucleic acid vector-induced toxicity in the inner earDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3352US2023061456A1Methods and compositions for generating type 1 vestibular hair cellsDECIBEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3451US2024148905A1Methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3548US2023181767A1Compositions and methods for promoting hair cell regenerationDECIBEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3647US12534739B2AAV1 vectors and uses thereof for treatment of otic indicationsDECIBEL THERAPEUTICS INC·Filed 2019·Granted Jan 27, 2026·0 cites·3 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →